Publications

ssessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials.

Cholesterol Treatment Trialists' (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk . and Cholesterol Treatment Trialists' (CTT) Collaboration ., (2026), Lancet

Polygenic prediction of coronary heart disease among 130,000 Mexican adults.

Liu T. et al, (2025), Eur J Prev Cardiol

lcohol and mortality in Mexico: prospective study of 150 000 adults.

Trichia E. et al, (2024), Lancet Public Health, 9, e907 - e915

Blood Pressure, eGFR, and Kidney Mortality in Mexico: A Prospective Study of 150,000 Adults

Zhu D., (2024)

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.

Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk . and Cholesterol Treatment Trialists’ (CTT) Collaboration ., (2024), Lancet Diabetes Endocrinol, 12, 306 - 319

Blood Pressure, eGFR, and Kidney Mortality in Mexico: A Prospective Study of 150,000 Adults

Zhu D. et al, (2024), JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 35

Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy.

Cholesterol Treatment Trialists' Collaboration ., (2022), Clin Trials, 19, 593 - 604

ngiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.

Pitcher A. et al, (2022), Lancet, 400, 822 - 831

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Cholesterol Treatment Trialists' Collaboration ., (2022), Lancet, 400, 832 - 845

Individual participant data meta-analysis of muscle symptoms in large-scale randomised double-blind trials of statin therapy

BAIGENT C. et al, (2022), The Lancet

Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis.

Marthi A. et al, (2018), J Am Soc Nephrol, 29, 2015 - 2027

Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.

Scally B. et al, (2018), Lancet Gastroenterol Hepatol, 3, 231 - 241

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.

Cholesterol Treatment Trialists' (CTT) Collaboration . et al, (2015), Lancet, 385, 1397 - 1405

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.

Coxib and traditional NSAID Trialists' (CNT) Collaboration . et al, (2013), Lancet, 382, 769 - 779

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.

Cholesterol Treatment Trialists' (CTT) Collaboration . et al, (2012), PLoS One, 7

Cookies on this website

Search results (18)